The flavonoid naringenin is commonly found in citrus fruits and tomato. The main aim of this study was to assess the in vitro insulin-like effects of naringenin using rat adipocyte primary culture. The adipogenic, lipolytic and glucose uptake activities of naringenin in primary rat adipocytes were assessed using Oil Red O, glycerol, and 2-deoxy-D- [2, H]glucose uptake quantitative assays respectively. Naringenin exhibited significant increase of lipogenesis in the presence and absence of insulin in primary rat preadipocytes. At the concentration range of 0.01 -100 µM, naringenin inhibited 50 % of epinephrine induced lipolysis in rat adipocytes and enhanced insulin's antilipolytic activity. Naringenin (100 µM) stimulated 163 % glucose uptake in rat adipocytes (compared to untreated cells) and this was significantly higher than the insulin mediated glucose uptake at similar concentration. Thus, naringenin may play an important role as an adjuvant and/or alternative to insulin therapy for the management of diabetes mellitus.
INTRODUCTION
Diabetes mellitus (DM) is a life-long metabolic disorder characterized by inability of glucose transportation from bloodstream into adipose tissue due to defects in insulin action, insulin secretion or both 1 . In the year 2000, the total number of people diagnosed with DM was 171 million but this number is estimated to increase to 366 million in the year 2030 2 . Type 2 DM is the most common form of diabetes which contributes to more than 85 % of all cases of diabetes worldwide 3 . This phenomenon is worrying because Type 2 DM usually occurs in conjunction with other metabolic syndrome including obesity, hypertension and dyslipidemia 4 . Obesity has a strong correlation with Type 2 DM and high prevalence of obesity had proven to cause epidemic condition of diabetes mellitus 5 . The adipocytes in obese individuals which are enlarged with high concentration of lipid develop resistance to insulin 6 .
Insulin plays an important role in regulating glucose and lipid metabolism. Insulin inhibits lipolysis elicited by epinephrine as well as promotes triglyceride storage in preadipocytes and glucose uptake in adipocytes 7 . The effects of insulin are counteracted by multiple hormones, such as glucagon, epinephrine, and isoproterenol which convert glycogen and triglyceride to glycerol 8 . Lipid metabolism in adipocytes has great influence on the occurrence of obesity and Type 2 DM. Hence, identification of compounds that are able to mimic insulin in lipid metabolism will add credence to the development of new anti-diabetic drugs or nutraceuticals that can be adjuvants to insulin therapy.
Flavonoids are plant metabolites with benzo-gamma-pyrone structure, which are found ubiquitously in all parts of plants 9 . Flavonoids are known to exert beneficial effects such as decrease total cholesterol, improve control of blood glucose concentration, and help in weight control in diabetic patients 10 . The flavonoid naringenin (4',5,7-trihydroxyflavanone) is commonly found in citrus fruits and tomato. Many experiments have been carried out with animal models to find a cure for obesity and DM. However the present study was conducted in vitro using primary rat preadipocytes as a cellular model, to investigate the insulin-like effects of naringenin.
MATERIALS AND METHODS

MATERIALS
All cell culture media and culture flasks were purchased from Sigma-Aldrich (St. Louis, USA) and Nunc (Naperville, IL, USA) respectively. Penicillin-Streptomycin-Glutamine and insulin were obtained from Invitrogen (Carlsbad, California) whereas 1-methyl-3-isobuylxanthine (IBMX), glycerol standard, dexamethasone, adenosine-5-triphosphate (ATP) and liquid scintillation counting cocktail were purchased from ICN (Aurora, Ohio). Phosphate-buffered saline tablets (PBS), Type-II collagenase and 2-deoxy-D-[2,6-3H]glucose were obtained from Flowlab (Sydney, Australia), Worthington Biochemical (Lakewood, New Jersey) and Amersham Biosciences (Piscataway, New Jersey) respectively. Epinephrine, isoproterenol, propanolol, 4-aminoantipyrine, N-ethyl-N-(3-sulfopropyl)-m-anisidine, sodium azide, naringenin and 2-deoxyglucose were obtained from Sigma-Aldrich (St. Louis, USA). Peroxidase, glycerokinase, and glycerol phosphate oxidase were purchased from Roche (Mannheim, Germany).
METHODS
TISSUE CULTURE
The intra-abdominal and epididymal fat pads were obtained from normal male Sprague-Dawley rats aged 6-8 weeks according to published articles with minor modifications 11 . Preadipocytes obtained were cultured in RPMI 1640 media supplemented with 2 mM penicillin-streptomycin-glutamine and 10 % foetal bovine serum (FBS). Upon confluency, the preadipocytes were differentiated with DMEM supplemented with penicillin-streptomycin-glutamine, 10 % FBS, 17 µM pantothenic acid, 0.5 mM IBMX, 1 µM dexamethasone, 10 µg/ml insulin and 33 µM biotin. After two days, IBMX and dexamethasone were removed from the differentiation media. The preadipocytes were allowed to differentiate in this media for up to 15 days.
PREPARATION OF NARINGENIN
Naringenin was dissolved in 100% DMSO and subsequently diluted to a concentration range of 0.01µM, 0.1µM, 1.0µM, 10µM and 100µM using 1% DMSO.
LIPOGENESIS ASSAY
Preadipocytes in 12-well tissue culture plate were incubated with naringenin in humidified air jacketed incubator containing 5 % CO 2 at 37 ?C. On Day-12 after the initiation of differentiation, the cells were fixed using 10 % formalin and the lipid accumulated during lipogenesis was stained with Oil Red O dye before quantified using spectrophotometer at 510nm.
LIPOLYSIS ASSAY
The glycerol released in lipolysis was measured according to the method by Trinder 12 . The glycerol reagent was prepared by mixing ATP, magnesium salt, 4-aminoantipyrine, sodium-N-ethyl-N0-(3-sulfopropyl)-m-anisidine, glycerol kinase, glycerol phosphate oxidase, peroxidase and TRIS buffer. Naringenin was incubated with the fully differentiated adipocytes at 37 ºC for 5 hours. Then, the glycerol reagent was added to the incubation mixture and the resulting colored complex was measured at 510nm.Quantitation was carried out using glycerol standard run concurrently with the incubations in the presence of the test compounds..
GLUCOSE UPTAKE ASSAY
The glucose label was prepared by mixing 2-deoxyglucose, 2-deoxy-D- [ 
RESULTS AND DISCUSSION
Adipose tissues are insulin-responsive; therefore they are widely used as the cellular model to investigate the biochemical pathways and physiological mechanisms related to diabetes and obesity. The adipocyte primary culture model can serve as a good platform for early assessment of potential hypoglycaemic agents and their properties against lipid metabolism. This could minimize the usage of large number of animals for such preliminary assessments.
In this study, confluent preadipocytes were induced to differentiate in DMEM media. Confluent state is an indicator of preadipocyte growth arrest stage, which is a prerequisite for the cells to become committed to adipocyte cell lineage 13 . Fully differentiated adipocytes accumulate lipid droplets in their cytoplasm. Insulin plays a vital role in preadipocyte differentiation/lipogenesis by activating insulin-signaling cascade (ISC) which leads to lipid metabolism as well as preadipocyte differentiation. Therefore, compounds that are able to induce lipogenesis could potentially have insulin-like property. The extent of lipogenesis was reflected by the amount of lipid accumulation in mature adipocytes. Naringenin showed very mild stimulation of lipogenesis in primry rat adipocytes at the concentration range tested with only 40 % stimulation at the maximum dose of 100 µM. When co-incubated with insulin, naringenin synergistically increased at least 50 % of insulin induced lipogenesis ( Figure 1 ). Lipolytic activity in adipocytes is highly dependant on hormone sensitive lipase (HSL), which is regulated by insulin and catecholamines 14 . Epinephrine is well known to stimulate lipolysis by promoting adenylate cyclase activity to increase cAMP level leading to the activation of HSL 15 . However, the activation of HSL could be blocked by insulin through the activation of cAMP phosphodiesterase (PDE) and stimulation of protein phosphatise-1, which in turn will lead to HSL dephosphorylation. Hence, epinephrine induced lipolysis in adipocytes was used as our model to investigate naringenin's antilipolitic activity. Epinephrine (1 µM) exerted 125 % of lipolysis whereas insulin (1 µM), an antilipolytic agent showed a baseline lipolytic level of 17 % lipolysis in primary rat adipocytes compared to untreated cells. At the concentration range of 0.01 -100 µM, naringenin inhibited almost 50 % of epinephrine induced lipolysis in rat adipocytes as well as enhanced insulin's antilipolytic activity (Figure 2 ). Insulin is also known to stimulate glucose uptake in adipocytes by activating several insulin-signalling proteins, namely insulin receptor substrates (IRS), phosphatidylinositol 3-kinase (PI3-K), and protein kinase B (PKB) 16 . The insulin-signalling proteins will eventually lead to the translocation of insulin-sensitive glucose transporter 4 (GLUT4) vesicles to the plasma membrane and facilitates glucose uptake into adipose tissue 16 . The present study showed that naringenin stimulated a significantly higher glucose uptake activity in primary rat adipocytes when compared to insulin. At a concentration of 100 µM, insulin stimulated 130 % glucose uptake whereas naringenin (100 µM) stimulated 163 % glucose uptake in rat adipocytes ( Figure 3 ). Insulin and some common antidiabetic drugs (e.g. Rosiglitazone) are known to have lipogenic, glucose uptake and epinephrine induced antilipolytic activities. Similarly, flavanoids which have been shown to have these activities were considered to be potential antidiabetic agents. Naringenin stimulated lipogenesis and glucose uptake but inhibited epinephrine induced lipolysis in adipocytes both in the presence and absence of insulin. These findings correlated with other studies using in vivo rat models which showed that naringenin helps to reduce blood glucose in streptozotocin-induced diabetic rats 17 , 18 . Hence, the foods rich in naringenin may be able to help attenuate the postprandial hyperglycemic state in diabetic patients. Naringenin could serve as a therapeutic agent or an adjuvant to insulin therapy in the management of diabetes mellitus.
CONCLUSION
Naringenin is an 'insulin-like' agent since it significantly induced adipogenesis in primary rat adipocytes but inhibited epinephrine induced lipolytic activity apart from exerting a higher efficacy in stimulating glucose uptake activity when compared to insulin. The exact pathways involved in the activation of insulin-like activities require further investigations and 
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